GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
B

Beigene 6160.HK · HKD

Health Care · HKEX · 🇭🇰 Hong Kong

Compare

248.20

+1.64%

Close of 9 Nov 2026, in HKD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

Beigene — daily HKEX:6160

No embeddable chart for this listing. TradingView's free widgets do not cover this exchange, and an unsupported symbol would render an error panel rather than a chart.

View Beigene on TradingView ↗
Market value
HK$339.45bn
Last close × shares
Volume
3.6m
Shares, 9 Nov 2026
Price to earnings
17.9

About Beigene

Its shares trade on HKEX under the ticker 6160.HK. It has been listed since 3 February 2016. In the fiscal year to 31 December 2025, it reported revenue of $43.03bn and net income of $2.31bn. At that date it held total assets of $64.45bn and shareholders' equity of $34.14bn.

BeiGene Ltd. is a commercial-stage biopharmaceutical company, which engages in the development and commercialization of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company is headquartered in Beijing, Beijing. The company went IPO on 2016-02-03. The firm is mainly engaged in the research and development, production and sales of innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The firm's main products include Zanubrutinib (BGB-3111), Tislelizumab (BGB-A317) and Pamiparib (BGB-290).

Figures and description from our data supplier, not checked against the company's own report.

More about Beigene →

Latest on Beigene

Our reporting

Next results

5 Nov 2026

Due on 5 Nov 2026. Analysts expect earnings of 1.15 a share.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is Beigene's ticker?

Beigene trades as 6160.HK on HKEX, under ISIN KYG1146Y1017.

What was Beigene's last closing price?

248.20 on 9 Nov 2026. The figure is in HKD and is never converted.

When does Beigene next report results?

Results are expected on 5 Nov 2026, according to our data supplier.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.